ECE2024 Oral Communications Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I (6 abstracts)
1University of Milan, Department of Medical Biotechnology and Translational Medicine, Milan, Italy; 2University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom; 3Birmingham Health Partners, Centre for Endocrinology, Diabetes and Metabolism, Birmingham, United Kingdom; 4Queen Elizabeth Hospital Birmingham, Department of Endocrinology, Birmingham, United Kingdom; 5University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, United Kingdom; 6Ospedale Niguarda Cà Granda, Unit of Endocrinology, Milan, Italy; 7IRCCS, Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy; 8University of Oxford, Kennedy Institute of Rheumatology, Birmingham, United Kingdom; 9University of Birmingham, Institute of Inflammation and Ageing, Birmingham, United Kingdom
Background: Pheochromocytoma is associated with systemic inflammation, but the underlying mechanisms are unclear. Hypothesising a putative effect of catecholamines on immune cells, we investigated the relationship between plasma metanephrine levels and haematological parameters as surrogates for systemic inflammation in patients with pheochromocytoma. Moreover, we aimed to assess the influence of preoperative α-blockade treatment on the inflammation-based scores.
Design and Methods: We included a retrospective cohort of 68 patients with pheochromocytoma who underwent adrenalectomy (mean age 53 years, 64.7% female) and two control groups matched for age, sex and body mass index: 68 patients with non-functioning adrenocortical tumours (NFAT) and 53 with essential hypertension. The full blood count and various inflammation-based scores [neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), Systemic Inflammation Index (SII), Prognostic-Nutrition Index (PNI)] were assessed in all patients at diagnosis and compared between the three groups. In addition, in a subgroup of pheochromocytomas, these parameters were compared before and after preoperative α-blockade treatment (n=29, median time 110 days, IQR 78.5-261.5) and before and after adrenalectomy (n=26, median time 15.6 months, IQR 5.7-42.3).
Results: A higher inflammatory state, as reflected by both full blood count and inflammation-based scores, was observed in patients with pheochromocytoma compared to NFAT and essential hypertension, whilst no differences were found between the two control groups. Notably, plasma metanephrine levels showed a positive correlation with NLR (r=0.4631), PLR (r=0.3174), SII (r=0.3709), and a negative correlation with LMR (r=0.4368) and PNI (r=0.3741), even after adjustment for age, sex, ethnicity, BMI, and tumor size, except for PLR. After adrenalectomy, we observed a significant increase in lymphocyte count (P=0.01) with corresponding changes in the relative inflammation-based scores. Specifically, a decrease in NLR (P=0.001), PLR (P=0.003), SII (P=0.004) and a concomitant increase in LMR (P=0.0002) were detected postoperatively. Similarly, α-blockade treatment led to a reduction in NLR (P=0.007) and SII (P=0.03).
Conclusions: The preoperative systemic inflammatory state observed in patients with pheochromocytoma, reflected by high NLR, PLR and SII, as well as low LMR and PNI, and ameliorated by adrenalectomy and α-blockade, is probably related to an excessive amount of secreted catecholamines. The impact of circulating catecholamines on the systemic inflammatory response may play a role in the cardio-metabolic comorbidities in patients with pheochromocytoma and may optimise treatment approaches.